Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Evidence Tools
Postpartum Contraception Use

Introduction

This toolkit summarizes content from the Postpartum Contraception Use Evidence Accelerator and the MCHbest database. The peer-reviewed literature supporting this work can be found in the Established Evidence database. Use the resources below as you develop effective evidence-based/informed programs and measures.

Postpartum Contracention Use is related to the following topics; see these Accelerators for additional information: Postpartum Visit and Postpartum Mental Health Screening.

From the MCH Block Grant Guidance. Contraception is recognized as an effective strategy for reducing unintended pregnancies and achieving healthy birth spacing thereby improving maternal and child health outcomes. In the United States, nearly two-thirds of reproductive-aged women report currently using contraception.1 However, those at greatest need for contraception may not be accessing or using it. In 2017-2019, 3 in 5 reproductive-aged women from 45 U.S. jurisdictions had an ongoing or potential need for contraceptive services; nearly one-third were not using a method of contraception at last sexual encounter.2 Long- acting reversible contraception methods are considered the most effective at preventing pregnancy, while short-acting reversible methods are moderately effective. Improving the uptake and use of these effective contraception methods in the postpartum period can prevent unintended pregnancies and improve health outcomes. Contraceptive care for postpartum women is part of the Core Set of Maternal and Perinatal Health Measures for Medicaid and CHIP.

Goal. To increase the percent of women who are using postpartum contraception.

Note. Access other related measures in this Population Domain through the Toolkits page.

Detail Sheet: Start with the MCH Block Grant Guidance

DEFINITION

Numerator:

Number of women who reported they are using a most effective (long-acting reversible contraceptive such as contraceptive implants and intrauterine devices or systems as well as irreversible surgical contraception) or moderately effective (injectables, oral pills, patches, rings, or diaphragms) method of contraception

Denominator:

Number of women with a recent live birth, excluding those who are currently pregnant

Units: 100

Text: Percent

HEALTHY PEOPLE 2030 OBJECTIVE

Related to Family Planning (FP) Objective 10: Increase the proportion of women at risk for unintended pregnancy who use effective birth control. (Baseline: 60.3% in 2015-17, Target: 65.1%)

DATA SOURCES

Pregnancy Risk Assessment Monitoring System (PRAMS)

MCH POPULATION DOMAIN

Women/Maternal Health

MEASURE DOMAIN

Health Behavior

1. Accelerate with EvidenceStart with the Science

The first step to accelerate effective, evidence-based/informed programs is ensuring that the strategies we implement are meaningful and have high potential to affect desired change. Read more about using evidence-based/informed programs and then use this section to find strategies that you can adopt or adapt for your needs.

Evidence-based/Informed Strategies: MCHbest Database

The following strategies have emerged from studies in the scientific literature as being effective in advancing the measure. Use the links below to read more about each strategy or access the MCHbest database to find additional strategies.

Chart of Evidence-Linked Strategies and Tools

Evidence-Informed

Evidence-Based

Mixed Evidence

Emerging Evidence

Expert Opinion

Moderate Evidence

Scientifically Rigorous

Field-Based Strategies: Resources and Programs

Resources from state-/community-based programs have been identified for advancing the NPM for specific communities or populations. They can be used as models to meet your program needs.

2. Think Upstream with Planning ToolsLead with the Need

The second step in developing effective, evidence-based/informed programs challenges us to plan upstream to ensure that our work addresses issues early and is measurable in “turning the curve” on big issues that face MCH populations. Read more about moving from root causes to responsive programs and then use this section to align your work with the data and needs of your populations.

Move from Need to Strategy

Use Root-Cause Analysis (RCA) and Results-Based Accountability (RBA) tools to build upon the science to determine how to address needs.

Planning Tools: Use these tools to move from data to action

3. Work Together with Implementation ToolsMove from Planning to Practice

The third step in developing effective, evidence-based/informed programs calls us to work together to ensure that programs are implementable and moveable within the realities of Title V programs and lead to improved health outcomes for all people. Read more about implementation tools designed for MCH population change and then use this section to develop responsive strategies to bring about change that is responsive to the needs of your populations.

Additional MCH Evidence Center Resources: Access supplemental materials from the literature

Implementation Resources: Use these field-generated resources to affect change

PRACTICE

The following tools can be used to translate evidence to action to advance this NPM:

  • Postpartum Contraception Guide (Partners in Contraceptive Choice and Knowledge). This decision aid helps provide patient-centered postpartum contraception counseling.
  • Immediate Postpartum Family Planning (Family Planning High Impact Practices). This issue brief provides practice information and implementation guidance for facility-based postpartum contraceptive counseling.

PARTNERSHIP

The following organizations focus on advancing postpartum contraception access:


References

Introductory References: From the MCH Block Grant Guidance

1 Daniels K, Abma JC. Current Contraceptive Status Among Women Aged 15-49: United States, 2017-2019. NCHS Data Brief. 2020;(388):1-8.

2 Zapata LB, Pazol K, Curtis KM, et al. Need for Contraceptive Services Among Women of Reproductive Age - 45 Jurisdictions, United States, 2017-2019. MMWR Morb Mortal Wkly Rep. 2021;70(25):910-915. Published 2021 Jun 25. doi:10.15585/mmwr.mm7025a2

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.